Furosemide Tablets — Class II drug recall D-0293-2026
Ongoing recall by Graviti Pharmaceuticals Private Limited, reported 2026-01-28, distributed nationwide. Presence of Foreign Substance
| Recall number | D-0293-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Graviti Pharmaceuticals Private Limited, Hyderabad, India |
| Recall initiated | 2026-01-10 |
| Classified | 2026-01-21 |
| Reported by FDA | 2026-01-28 |
| Distributed | Nationwide (US) |
| Quantity | 4,212 bottles |
| NDC | 64980-0562, 64980-0562-01, 64980-0562-10, 64980-0563, 64980-0563-01, 64980-0563-10, 64980-0564, 64980-0564-01, 64980-0564-50 |
| Lot numbers | FUB125042G |
| Expiration dates | 2027-05-13 |
Product
Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.
Reason for recall
Presence of Foreign Substance
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0293-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.